- Home
- PRGS vs AVDL Comparison
PRGS vs AVDL Comparison
Compare PRGS & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGS
- AVDL
- Stock Information
- Founded
- PRGS 1981
- AVDL 2015
- Country
- PRGS United States
- AVDL Ireland
- Employees
- PRGS N/A
- AVDL N/A
- Industry
- PRGS Computer Software: Prepackaged Software
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- PRGS Technology
- AVDL Health Care
- Exchange
- PRGS Nasdaq
- AVDL Nasdaq
- Market Cap
- PRGS 1.8B
- AVDL 1.5B
- IPO Year
- PRGS 1991
- AVDL 1996
- Fundamental
- Price
- PRGS $45.81
- AVDL $15.16
- Analyst Decision
- PRGS Strong Buy
- AVDL Strong Buy
- Analyst Count
- PRGS 6
- AVDL 8
- Target Price
- PRGS $70.00
- AVDL $20.88
- AVG Volume (30 Days)
- PRGS 1.3M
- AVDL 1.2M
- Earning Date
- PRGS 09-29-2025
- AVDL 11-11-2025
- Dividend Yield
- PRGS N/A
- AVDL N/A
- EPS Growth
- PRGS N/A
- AVDL N/A
- EPS
- PRGS 1.09
- AVDL N/A
- Revenue
- PRGS $940,126,000.00
- AVDL $221,075,000.00
- Revenue This Year
- PRGS $32.15
- AVDL $64.21
- Revenue Next Year
- PRGS $1.65
- AVDL $30.80
- P/E Ratio
- PRGS $41.83
- AVDL N/A
- Revenue Growth
- PRGS 31.41
- AVDL 132.35
- 52 Week Low
- PRGS $40.29
- AVDL $6.38
- 52 Week High
- PRGS $70.56
- AVDL $16.66
- Technical
- Relative Strength Index (RSI)
- PRGS 53.29
- AVDL 56.53
- Support Level
- PRGS $44.62
- AVDL $13.83
- Resistance Level
- PRGS $47.11
- AVDL $14.61
- Average True Range (ATR)
- PRGS 1.70
- AVDL 0.49
- MACD
- PRGS 0.31
- AVDL -0.13
- Stochastic Oscillator
- PRGS 76.01
- AVDL 66.85
About PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.